Cargando…
Therapeutic activity of a combination of immunostimulatory monoclonal antibodies (anti-B7-H1, CD137 and OX40) on a c-myc-driven spontaneous transgenic model of hepatocellular carcinoma
Autores principales: | Morales-Kastresana, Aizea, Miguel, Sanmamed F, Rodriguez, Inmaculada, Palazon, Asis, Martinez-Forero, Ivan, Labiano, Sara, Hervas-Stubbs, Sandra, Sangro, Bruno, Ochoa, Carmen, Rouzaut, Ana, Azpilikueta, Arantza, Bolaños, Elixabet, Jure-Kunkel, Maria, Gutgemann, Ines, Melero, Ignacio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3990327/ http://dx.doi.org/10.1186/2051-1426-1-S1-O7 |
Ejemplares similares
-
Essential complicity of perforin-granzyme and FAS-L mechanisms to achieve tumor rejection following treatment with anti-CD137 mAb
por: Morales-Kastresana, Aizea, et al.
Publicado: (2013) -
Hypoxia-induced soluble CD137 in malignant cells blocks CD137L-costimulation as an immune escape mechanism
por: Labiano, Sara, et al.
Publicado: (2014) -
Combinations of immunostimulatory antibodies with synergistic effects against spontaneous cancer
por: Morales-Kastresana, Aizea, et al.
Publicado: (2014) -
Focusing and sustaining the antitumor CTL effector killer response by agonist anti-CD137 mAb
por: Bolaños-Mateo, Elixabet, et al.
Publicado: (2014) -
Dendritic Cells Take up and Present Antigens from Viable and Apoptotic Polymorphonuclear Leukocytes
por: Alfaro, Carlos, et al.
Publicado: (2011)